Chronic intestinal inflammation persistently decreases frequency of mucosal CD5⁺ B cells. by Yoshiyuki Mishima (842248)

Chronic intestinal inflammation persistently decreases frequency of mucosal CD5⁺ B cells. by Yoshiyuki Mishima (842248)

Decreased cell viability and ROS production induced by oxidative treatment. by Sandra M. Martín-Guerrero (780940)

AILV-V RNA-2 accumulation varies in the same leaf, progressively decreasing moving to the successive leaf. by Elisa Santovito (575029)

Overexpression of Pax6 decreases Olig2 protein levels. by Eun Sook Jang (217069)

“…(<b>a</b>) Oli-Neu cells were transfected with flag-tagged WT Pax6 (WT), Pax6(5a)R128C (128), or eGFP control vector (-). …”

Decreased natTregs observed in the lungs in the absence of TLR2. by Amanda McBride (421742)

Nicotine decreased Wnt5a expressions in SK-BR-3 cells. by Masanori A. Murayama (5774585)

L665W decreased AR5A binding to H77/JFH1 particles and to the E1/E2 complex in H77/JFH1 infected cells, but did not alter receptor dependency. by Rodrigo Velázquez-Moctezuma (3776023)

Nsp8 decreases antiviral immune and inflammatory responses and promotes SARS-CoV-2 infection. by Xiaolin Zhang (246784)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

LPS decreases only T cell proliferative response to OKT3. by Fanny Poujol (834338)

53BP1 protein abundance decreases upon irradiation. by Yiheng Hu (648082)

Increased data compression and variability with decreasing spot TD intensity by Xujing Wang (21247)

Adoptive transfer of mature NK cells decreases the incidence of BA and improves survival, and the level of VP4 in cholangiocytes and the incidence of BA are decreased as the age of... by Yinrong Qiu (345978)

CPSF6 protein expression is decreased in virus-infected cells. by Yong Ge (816832)

HDAC inhibition by TSA decreases SREBP2 proteolytic cleavage. by Maria João Nunes (160499)

R848 mediated RANTES, but not TNF-α production, is significantly decreased in TRAM^−/− iBMDMs. by Enda Shevlin (628477)

Inhibition of IL-17A at tumor sites decreases the intratumoral microvessel density. by Keiji Hayata (277090)

“…<p>(A) The endothelial maker CD31-stained sections of tumor tissue are shown in Ad-SNC and Ad-si-IL-17 treatment models, Ad-si-IL-17 treatment decreased the intratumoral microvessel density compared with Ad-SNC. …”

Multivariable Linear Regression Model of the Residents P-V Fit score^a. by Yaotian Fan (5917766)